Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 49 Records) |
| Query Trace: Colorectal Neoplasms and ABCB1[original query] |
|---|
| Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment. Pharmacogenetics and genomics 2013 Oct 23 (10): 549-57. De Mattia Elena, Toffoli Giuseppe, Polesel Jerry, D'Andrea Mario, Corona Giuseppe, Zagonel Vittorina, Buonadonna Angela, Dreussi Eva, Cecchin Eri |
| Associations of ABCB1 and XPC genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis in a Chinese population. Asian Pacific journal of cancer prevention : APJCP 2013 14 (5): 3085-91. Yue Ai-Min, Xie Zhen-Bin, Zhao Hong-Feng, Guo Shu-Ping, Shen Yu-Hou, Wang Hai- |
| Association of ABCB1 genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis. Pharmacogenomics 2013 Jun 14 (8): 897-911. Wu Huizhe, Kang Hui, Liu Yong, Xiao Qinghuan, Zhang Yining, Sun Mingjun, Liu Duo, Wang Zhe, Zhao Haishan, Yao Weifan, Jia Tianhong, Wang Enhua, Zheng Zhihong, Wei Minj |
| Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer. Cancer chemotherapy and pharmacology 2013 Jun 71 (6): 1463-72. Cortejoso Lucía, García María I, García-Alfonso Pilar, González-Haba Eva, Escolar Fernando, Sanjurjo María, López-Fernández Luis |
| Association between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibility : a meta-analysis based on 11,339 subjects. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Jun 34 (3): 1949-57. Zhao Li, Li Kai, Li Wusheng, Yang Zh |
| Meta-Analysis of ABCB1 3435C>T Polymorphism and Colorectal Cancer. Pakistan journal of medical sciences 2013 Sep 29 (5): 1269-74. Zhang Dan, Wang Cun, Zhou Zonggua |
| [Validation of genetic polymorphisms associated to the toxicity of chemotherapy in colorectal cancer patients]. Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria 0 38 (4): 283-90. Cortejoso L, García M I, García-Alfonso P, Grávalos C, Robles L, González-Haba E, Sanjurjo M, López-Fernández L |
| Interactions between meat intake and genetic variation in relation to colorectal cancer. Genes & nutrition 2015 Jan 10 (1): 448. Andersen Vibeke, Vogel Ul |
| Colorectal cancer susceptibility: apparent gender-related modulation by ABCB1 gene polymorphisms. Journal of biomedical science 2014 21 89. Martinelli Marcella, Scapoli Luca, Cura Francesca, Rodia Maria Teresa, Ugolini Giampaolo, Montroni Isacco, Solmi Rossel |
| ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients. Pharmacogenetics and genomics 2015 Sep . Chen Sylvia, Villeneuve Lyne, Jonker Derek, Couture Félix, Laverdière Isabelle, Cecchin Erica, Innocenti Federico, Toffoli Giuseppe, Lévesque Eric, Guillemette Chant |
| Two SNPs of ATP-binding cassette B1 gene on the risk and prognosis of colorectal cancer. International journal of clinical and experimental pathology 2015 8 (3): 3083-9. Wang Fei, Huang Zonghai, Zheng Kehong, Zhao Haiping, Hu Wenx |
| Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study. Scandinavian journal of gastroenterology 2015 Dec 50 (12): 1469-81. Kopp Tine Iskov, Andersen Vibeke, Tjonneland Anne, Vogel Ul |
| Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer. Oncotarget 2015 Mar 6 (8): 6422-30. García-González Xandra, Cortejoso Lucía, García María I, García-Alfonso Pilar, Robles Luis, Grávalos Cristina, González-Haba Eva, Marta Pellicer, Sanjurjo María, López-Fernández Luis |
| Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. Cancer chemotherapy and pharmacology 2015 Apr 75 (4): 763-72. Joerger M, Huitema A D R, Boot H, Cats A, Doodeman V D, Smits P H M, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny T D, Beijnen J H, Schellens J H |
| Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228). British journal of cancer 2017 Aug . Lévi Francis, Karaboué Abdoulaye, Saffroy Raphaël, Desterke Christophe, Boige Valerie, Smith Denis, Hebbar Mohamed, Innominato Pasquale, Taieb Julien, Carvalho Carlos, Guimbaud Rosine, Focan Christian, Bouchahda Mohamed, Adam René, Ducreux Michel, Milano Gérard, Lemoine Antoinet |
| Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan. Pharmacological research 2018 Sep 136 133-139. Salvador-Martín Sara, García-González Xandra, García María I, Blanco Carolina, García-Alfonso Pilar, Robles Luis, Grávalos Cristina, Pachón Vanessa, Longo Federico, Martínez Virginia, Sanjurjo-Sáez María, López-Fernández Luis |
| Effect of UGT, SLCO, ABCB and ABCC polymorphisms on irinotecan toxicity. Medicina clinica 2018 Feb . García Gil Sara, Ramos Díaz Ruth, Nazco Casariego Gloria Julia, Llanos Muñoz Marta, Viña Romero Maria Micaela, Martín Calero Braulio, Pérez Pérez Jose Antonio, Gutiérrez Nicolás Fernan |
| Irinotecan toxicity during treatment of metastatic colorectal cancer: focus on pharmacogenomics and personalized medicine. Tumori 2018 12 106 (2): 87-94. Paulík Adam, Nekvindová Jana, Filip Stanisl |
| Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers. Therapeutic advances in medical oncology 2019 6 11 1758835919846421. Bruera Gemma, Massacese Silvia, Pepe Francesco, Malapelle Umberto, Dal Mas Antonella, Ciacco Eugenio, Calvisi Giuseppe, Troncone Giancarlo, Simmaco Maurizio, Ricevuto Enri |
| Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? The pharmacogenomics journal 2019 Feb . Nichetti Federico, Falvella Felicia Stefania, Miceli Rosalba, Cheli Stefania, Gaetano Raffaella, Fucà Giovanni, Infante Gabriele, Martinetti Antonia, Antoniotti Carlotta, Falcone Alfredo, Di Bartolomeo Maria, Cremolini Chiara, de Braud Filippo, Pietrantonio Filip |
| Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancer. The pharmacogenomics journal 2019 Dec . Reynolds Ian S, O'Connell Emer, Fichtner Michael, McNamara Deborah A, Kay Elaine W, Prehn Jochen H M, Furney Simon J, Burke John |
| Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient With KRAS Mutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemotherapy. Frontiers in oncology 2020 8 10 1155. Bruera Gemma, D'Andrilli Antonio, Simmaco Maurizio, Guadagni Stefano, Rendina Erino Angelo, Ricevuto Enri |
| Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy. Scientific reports 2020 Aug 10 (1): 13486. Atasilp Chalirmporn, Chansriwong Phichai, Sirachainan Ekaphop, Reungwetwattana Thanyanan, Sirilerttrakul Suwannee, Chamnanphon Monpat, Puangpetch Apichaya, Sukasem Chonlaph |
| ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients. Frontiers in pharmacology 2020 7 11 973. Riera Pau, Artigas-Baleri Alícia, Salazar Juliana, Sebio Ana, Virgili Anna C, Arranz María Jesús, Páez Dav |
| Influence of ABCB-1, ERCC-1 and ERCC-2 gene polymorphisms on response to capecitabine and oxaliplatin (CAPOX) treatment in colorectal cancer (CRC) patients of South India. Journal of clinical pharmacy and therapeutics 2020 May . Varma Ashok, Mathaiyan Jayanthi, Shewade Deepak, Dubashi Biswajit, Sunitha Kodide |
| ABCB1 variants C3435T and T129C are not associated with colorectal cancer risk. African health sciences 2019 Sep 19 (3): 2476-2483. Al Qahtani Areej M, Al-Ghafari Ayat B, Al Doghaither Huda A, Alzahrani Anas H, Omar Ulfat M, Rahimulddin Sawsan |
| Association between ABCB1 (3435C>T) polymorphism and susceptibility of colorectal cancer: A meta-analysis. Medicine 2020 Feb 99 (8): e19189. Han Li-Li, Zuo Bai-le, Cai Wei-Liang, Guo Zhen-Ni, Tong Bing-Hua, Wei Hui-Lian, Zhu Zheng, Li Guo-Y |
| The MDR1/ABCB1 gene rs 1045642 polymorphism in colorectal cancer. Archives of medical science : AMS 2020 16 (1): 112-117. Mrozikiewicz-Rakowska Beata, Malinowski Marian, Nehring Piotr, Bartkowiak-Wieczorek Joanna, Bogacz Anna, ?urawi?ska-Grzelka Ewa, Krasnod?bski Przemys?aw, Muszy?ski Jacek, Grzela Tomasz, Przyby?kowski Adam, Czupryniak Lesz |
| A polymorphism in ABCA2 is associated with neutropenia induced by capecitabine in Japanese patients with colorectal cancer. Cancer chemotherapy and pharmacology 2023 8 . Yukitaka Shibata, Natsumi Matsumoto, Remi Murase, Yutaro Kubota, Hiroo Ishida, Ken Shimada, Ken-Ichi Fuji |
| Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study. Current oncology (Toronto, Ont.) 2024 1 31 (1): 274-295. Juan Pablo Cayún, Leslie Carol Cerpa, Alicia Colombo, Dante Daniel Cáceres, José Luis Leal, Felipe Reyes, Carolina Gutiérrez-Cáceres, Susan Calfunao, Nelson Miguel Varela, Luis Abel Quiñon |
- Page last reviewed:Feb 1, 2024
- Content source: